Preferred Label : bosutinib;

MeSH note : a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases; structure in first source;

CISMeF synonym : SKI606;

MeSH hyponym : SKI-606;

MeSH Related Number : 380443-75-4;

Registry Number MeSH : 380443-75-4;

Is substance : O;

UNII : 5018V4AEZ0;

InChIKey : UBPYILGKFZZVDX-UHFFFAOYSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3098041/fr/bosulif
2019
false
false
false
France
bosutinib
bosutinib
treatment outcome
adult
antineoplastic agents
protein kinase inhibitors
leukemia, myelogenous, chronic, bcr-abl positive
evaluation of the transparency committee
aniline compounds
nitriles
quinolines

---
https://www.has-sante.fr/jcms/p_3097600/fr/bosulif
2019
false
false
false
France
bosutinib
administration, oral
treatment outcome
leukemia, myeloid, chronic-phase
Philadelphia chromosome positive chronic myelogenous leukemia (disorder)
antineoplastic agents
protein kinase inhibitors
bosutinib
adult
evaluation of the transparency committee
aniline compounds
nitriles
quinolines

---
http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BCR-ABL-Imatinib-Dasatinib-Nilotinib-Bosutinib-Ponatinib-Medicament-ciblant-JAK-Ruxolitinib-Anticancereux-par-voie-orale-informer-prevenir-et-gerer-leurs-effets-indesirables
2016
false
false
false
France
French
practice guideline
antineoplastic agents
administration, oral
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
information dissemination
patient education as topic
drug interactions
Dasatinib
Imatinib Mesylate
fusion proteins, bcr-abl
protein kinase inhibitors
dasatinib
imatinib
nilotinib
nilotinib
bosutinib
ponatinib
ruxolitinib
janus kinases
ponatinib
ruxolitinib
bosutinib
continuity of patient care
pregnancy
Tyrosine Kinase Inhibitors
nilotinib
ruxolitinib
aniline compounds
nitriles
quinolines
imidazoles
pyridazines
pyrimidines
pyrazoles

---
BCR-ABL Tyrosine Kinase Inhibitors [GLEEVEC (imatinib mesylate), TASIGNA (nilotinib), BOSULIF (bosutinib), SPRYCEL (dasatinib), ICLUSIG (ponatinib hydrochloride)] - Risk of Hepatitis B Reactivation
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-fra.php
2016
false
false
false
Canada
French
English
pharmacovigilance note
fusion proteins, bcr-abl
protein kinase inhibitors
Imatinib Mesylate
risk
hepatitis b virus
imatinib
nilotinib
nilotinib
bosutinib
bosutinib
Dasatinib
dasatinib
ponatinib hydrochloride
ponatinib
Tyrosine Kinase Inhibitor
Hepatitis B reactivation
guidelines for drug use
continuity of patient care
mass screening
hepatitis B
hepatitis B
Tyrosine Kinase Inhibitors
nilotinib
ponatinib
pyrimidines
imidazoles
pyridazines
aniline compounds
nitriles
quinolines

---
http://www.e-cancer.fr/content/download/126025/1524695/file/Médicaments%20ciblant%20BCR-ABL.pdf
2015
false
false
false
France
French
practice guideline
guidelines for drug use
administration, oral
antineoplastic agents
Drug-Related side effects and adverse reactions
imatinib
dasatinib
nilotinib
nilotinib
bosutinib
bosutinib
ponatinib
ponatinib
protein kinase inhibitors
ruxolitinib
ruxolitinib
janus kinases
information dissemination
continuity of patient care
hospital-physician relations
hospital-patient relations
physician-patient relations
drug interactions
pregnancy
protein-tyrosine kinases
Tyrosine Kinase Inhibitor
Dasatinib
Imatinib Mesylate
Tyrosine Kinase Inhibitors
nilotinib
ruxolitinib
pyrazoles
aniline compounds
nitriles
quinolines
imidazoles
pyridazines

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=63150294
2014
false
false
false
France
French
summary of product characteristics
package leaflet
bosutinib
bosutinib
tablets
pill, nos
compression, nos
bosutinib
dandruff
seborrhea sicca
dandruff
aniline compounds
nitriles
quinolines

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60462965
2014
false
false
false
France
French
summary of product characteristics
package leaflet
pill, nos
compression, nos
bosutinib
bosutinib
seborrhea sicca
tablets
dandruff
bosutinib
dandruff
aniline compounds
nitriles
quinolines

---
http://www.has-sante.fr/portail/jcms/c_1730843/fr/bosulif-bosutinib-inhibiteur-de-tyrosine-kinase
2014
false
false
false
France
French
English
evaluation of the transparency committee
guidelines for drug use
administration, oral
bosutinib
bosutinib
bosutinib
adult
leukemia, myeloid, chronic-phase
leukemia, myeloid, accelerated phase
blast crisis
protein kinase inhibitors
protein kinase inhibitors
insurance, health, reimbursement
treatment outcome
survival analysis
aniline compounds
nitriles
quinolines
aniline compounds
nitriles
quinolines

---
https://www.ema.europa.eu/medicines/human/EPAR/Bosulif
2013
false
United Kingdom
French
bosutinib
orphan drug production
bosutinib
adult
leukemia, myeloid, accelerated phase
leukemia, myeloid, chronic-phase
blast crisis
administration, oral
drug interactions
pregnancy
breast feeding
fertility
protein kinase inhibitors
protein kinase inhibitors
treatment outcome
clinical trials as topic
antineoplastic agents
antineoplastic agents
summary of product characteristics
package leaflet
syndication feed
survival analysis
disease-free survival
Progression-Free survival
drug evaluation, preclinical
drug approval
europe
aniline compounds
aniline compounds
nitriles
nitriles
quinolines
quinolines
bosutinib

---
Nous contacter.
17/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.